Why This Biotech Plummeted Despite Its 'Best-Case' Study - Investor's Business Daily
Source:Investor's Business Daily
Abivax stock crashed Monday after several patients developed cancer following a study of its ulcerative colitis treatment.
Related Articles
US unemployment insurance weekly claims - Forex Factory
In the week ending February 21, the advance figure for seasonally adjusted initial claims was …
Hassett says Fed staff should be 'disciplined' for reporting the US pays tariff costs - Politico
The Trump economic adviser called it “the worst paper I’ve ever seen in the history of the Federal …
TikTok Star Khaby Lame Signs $975 Million Deal to Monetize Global Fan Base - Bloomberg
Khaby Lame, the world’s biggest TikToker, partnered with Rich Sparkle Holdings Ltd. to transform his …
Historic winter storms weigh on Gap, Old Navy performance after 800 temporary store closures - CNBC
Gap has been on a steady upswing of growth but saw worse than expected results during its holiday …